These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 10601132
1. Step-down of enalapril treatment for arterial hypertension. González-Juanatey JR, Reino AP, García-Acuña JM, González-Juanatey C, Valdes L, Cabezas-Cerrato J. Hypertension; 1999 Dec; 34(6):1287-92. PubMed ID: 10601132 [Abstract] [Full Text] [Related]
3. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril. Seara FJ, Juanatey JR, Sande JL, Veloso PR, Reino AP, Román AV, Cerrato JC, Peña MG. Ann Noninvasive Electrocardiol; 2003 Jan; 8(1):47-54. PubMed ID: 12848813 [Abstract] [Full Text] [Related]
4. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. González-Juanatey JR, García-Acuña JM, Pose A, Varela A, Calvo C, Cabezas-Cerrato J, de la Peña MG. Am J Cardiol; 1998 Jan 15; 81(2):170-4. PubMed ID: 9591900 [Abstract] [Full Text] [Related]
6. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril. González-Juanatey JR, Pose Reino A, Román AV, García Acuña JM, Fernández López JA, Cerrato JC. Am J Cardiol; 1997 Feb 01; 79(3):373-6. PubMed ID: 9036764 [Abstract] [Full Text] [Related]
8. [Effect of enalapril on left ventricular hypertrophy and left ventricular function in patients with hypertension]. Kakinoki S, Takechi S, Hashimoto M, Sakuma I, Nomura A, Kitabatake A, Yasuda H. Kokyu To Junkan; 1993 Dec 01; 41(12):1185-9. PubMed ID: 8284542 [Abstract] [Full Text] [Related]
10. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J. Int J Clin Pharmacol Ther; 1997 Jan 01; 35(1):38-42. PubMed ID: 9021441 [Abstract] [Full Text] [Related]
11. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment. González-Juanatey JR, Pose Reino A, García Acuña JM, Castelo Fuentes V, Amaro Gendón A, Calvo Gómez C, Gil de la Peña M. Eur Heart J; 1995 Dec 01; 16(12):1981-7. PubMed ID: 8682036 [Abstract] [Full Text] [Related]
13. Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals. Beck AL, Otto ME, D'Avila LB, Netto FM, Armendaris MK, Sposito AC. Atherosclerosis; 2012 Jun 01; 222(2):444-8. PubMed ID: 22554359 [Abstract] [Full Text] [Related]
16. Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects. de Divitiis O, Galderisi M, Celentano A, Tammaro P, Garofalo M, Palmieri V, Crivaro M, Assogna G, Zanna C. J Int Med Res; 1993 Jun 01; 21(3):113-25. PubMed ID: 8299854 [Abstract] [Full Text] [Related]
19. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril. Leenen FH, Myers MG, Joyner CD, Toal CB. Can J Cardiol; 2002 Dec 01; 18(12):1285-93. PubMed ID: 12518180 [Abstract] [Full Text] [Related]
20. Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients. De Rosa ML, Cardace P, Rossi M, Baiano A, de Cristofaro A. J Hum Hypertens; 2002 Feb 01; 16(2):133-40. PubMed ID: 11850771 [Abstract] [Full Text] [Related] Page: [Next] [New Search]